» Articles » PMID: 29233723

The Different Faces of the P. A53T Alpha-synuclein Mutation: A Screening of Greek Patients with Parkinsonism And/or Dementia

Overview
Journal Neurosci Lett
Specialty Neurology
Date 2017 Dec 14
PMID 29233723
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The p. A53T mutation in the alpha-synuclein (SNCA) gene is a rare cause of autosomal dominant Parkinson's disease (PD). Although generally rare, it is particularly common in the Greek population due to a founder effect. A53T-positive PD patients often develop dementia during disease course and may very rarely present with dementia.

Methods: We screened for the p. A53T SNCA mutation a total of 347 cases of Greek origin with parkinsonism and/or dementia, collected over 15 years at the Neurogenetics Unit, Eginition Hospital, University of Athens. Cases were classified into: "pure parkinsonism", "pure dementia" and "parkinsonism plus dementia".

Results: In total, 4 p. A53T SNCA mutation carriers were identified. All had autosomal dominant family history and early onset. Screening of the "pure parkinsonism" category revealed 2 cases with typical PD. The other two mutation carriers were identified in the "parkinsonism plus dementia" category. One had a diagnosis of PD dementia and the other of behavioral variant frontotemporal dementia. Screening of patients with "pure dementia" failed to identify any further A53T-positive cases.

Conclusions: Our results confirm that the p. A53T SNCA mutation is relatively common in Greek patients with PD or PD plus dementia, particularly in cases with early onset and/or autosomal dominant family history.

Citing Articles

The novel p.A30G SNCA pathogenic variant in Greek patients with familial and sporadic Parkinson's disease.

Alefanti I, Koros C, Tsami V, Simitsi A, Kartanou C, Papagiannakis N Eur J Neurol. 2025; 32(2):e16562.

PMID: 39878395 PMC: 11775907. DOI: 10.1111/ene.16562.


Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson's Disease.

Akrioti E, Karamitros T, Gkaravelas P, Kouroupi G, Matsas R, Taoufik E Biomolecules. 2022; 12(7).

PMID: 35883433 PMC: 9313424. DOI: 10.3390/biom12070876.


Cognitive Impairment in Genetic Parkinson's Disease.

Planas-Ballve A, Vilas D Parkinsons Dis. 2022; 2021:8610285.

PMID: 35003622 PMC: 8739522. DOI: 10.1155/2021/8610285.


A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease.

Fevga C, Park Y, Lohmann E, Kievit A, Breedveld G, Ferraro F Parkinsonism Relat Disord. 2021; 89:63-72.

PMID: 34229155 PMC: 8607441. DOI: 10.1016/j.parkreldis.2021.06.023.


The Role of White Matter Dysfunction and Leukoencephalopathy/Leukodystrophy Genes in the Aetiology of Frontotemporal Dementias: Implications for Novel Approaches to Therapeutics.

Lok H, Kwok J Int J Mol Sci. 2021; 22(5).

PMID: 33802612 PMC: 7961524. DOI: 10.3390/ijms22052541.